ADVM Adverum Biotechnologies
- 4.2700
- -0.2500-5.53%
- 4.2700
- 0.00000.00%
Adverum Biotechnologies所有资讯
Adverum Biotechnologies | S-8：员工福利计划证券登记
Adverum Biotechnologies | SCHEDULE 13G：其他
Adverum Biotechnologies | 8-K：重大事件
Adverum Biotechnologies | SC 13G/A：超过5%持股股东披露文件(修正)-Vivo Opportunity Fund Holdings, L.P.(1.1%),Vivo Opportunity, LLC(1.1%)
Adverum Biotechnologies | SC 13G/A：超过5%持股股东披露文件(修正)-Logos Global Management LP(2.0%),Logos Global Management GP LLC(2.0%)等
Adverum Biotechnologies | SC 13G/A：超过5%持股股东披露文件(修正)-Commodore Capital LP(0%),Commodore Capital Master LP(0%)
Adverum Biotechnologies | SC 13G/A：超过5%持股股东披露文件(修正)-FMR LLC(1.128%),Abigail P. Johnson(1.128%)
Adverum Biotechnologies | SC 13G：超过5%持股股东披露文件-BlackRock, Inc.(7.2%)
Adverum Biotechnologies | SC 13G/A：超过5%持股股东披露文件(修正)-Morgan Stanley(0.4%),Morgan Stanley Capital Services LLC(0.1%)
Adverum Biotechnologies | 10-Q：2024财年三季报
Adverum Biotechnologies | 8-K：Adverum Biotechnologies公布2024年第三季度财务业绩，提供公司要点并更新预期里程碑
Adverum Biotechnologies | SCHEDULE 13G：其他
Adverum Biotechnologies | SC 13G：超过5%持股股东披露文件-Augustus Stern, MD(5.37%)
Adverum Biotechnologies | SC 13G：超过5%持股股东披露文件-Principia Wealth Advisory, LLC, EIN: 27-1545452(5.07%)
Adverum Biotechnologies | SC 13G：超过5%持股股东披露文件-BlackRock, Inc.(7.2%)
Adverum Biotechnologies | 10-Q：2024财年二季报
Adverum Biotechnologies | 8-K：Adverum Biotechnologies公布2024年第二季度财务业绩并提供计划和公司摘要
Adverum Biotechnologies | 4：持股变动声明-高管 Soparkar Peter
Adverum Biotechnologies | 4：持股变动声明-高管 Seyedkazemi Setareh
Adverum Biotechnologies | 4：持股变动声明-高管 Rubinstein Linda M
暂无数据